Zobrazeno 1 - 10
of 474
pro vyhledávání: '"M.P. Laguna"'
Autor:
J.L. Boormans, J. Mayor De Castro, C. Fankhauser, F. Algaba, C. Bokemeyer, K. Fizzazi, H. Gremmels, N. Nicolai, D. Nicol, J. Oldenburg, R. Sylvester, M.P. Laguna
Publikováno v:
European Urology Open Science, Vol 19, Iss , Pp e1806-e1807 (2020)
Externí odkaz:
https://doaj.org/article/9256f47f91024ec698d21f747ae1a948
Autor:
Varaha S Tammisetti, Peter-Paul Willemse, Daniel Rukstalis, Veeru Kasivisvanathan, Xavier Cathelineau, Yoh Matsuoka, Willemien Van Den Bos, Giorgio Gandaglia, Soroush Rais-Bahrami, Takumi Shiraishi, Massimo Valerio, Ardeshir R. Rastinehad, Cary N. Robertson, Herbert Lepor, Rajan T Gupta, Juan Gomez Rivas, Toshitaka Shin, Ariel Schulman, Yann Barbe, A.L. Abreu, Marco Moschini, Arvin K. George, Marco Oderda, Armando Stabile, Amir H. Lebastchi, Nathan Lawrentschuk, Daniel Margolis, Georg Salomon, M.P. Laguna, Wei Phin Tan, Jean J.M.C.H. de la Rosette, Derek Lomas, Christian P Pavlovich, Hazem Orabi, Bernard Malavaud, Abhinav Sidana, Osamu Ukimura, Sherif Mehralivand, Justin Gregg, Fernando Bianco, Thomas J. Polascik, Jochen Walz, Giancarlo Marra, Petr Macek, Rafael Sanchez-Salas, Sunao Shoji, Mesut Remzi, A. Villers
Publikováno v:
Minerva Urology and Nephrology, 74(5), 581-589. Edizioni Minerva Medica S.p.A.
Minerva Urology and Nephrology, 74(5), 581-589. Edizioni Minerva Medica
Minerva Urology and Nephrology, 74(5), 581-589. Edizioni Minerva Medica
Background Focal Therapy (FT) for Prostate Cancer (PCa) is promising. However, long-term oncological results are awaited and there is no consensus on follow-up strategies. Molecular biomarkers (MB) may be useful in selecting, treating and following u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc5674c39c2c1157340f1c0353262367
https://pure.amc.nl/en/publications/molecular-biomarkers-in-the-context-of-focal-therapy-for-prostate-cancer(df7bf651-87c7-44e5-bf47-9d2e9141567d).html
https://pure.amc.nl/en/publications/molecular-biomarkers-in-the-context-of-focal-therapy-for-prostate-cancer(df7bf651-87c7-44e5-bf47-9d2e9141567d).html
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Hew, M.N., Baseskioglu, B., Barwari, K., Axwijk, P.H., Can, C., Horenblas, S., Bex, A., Rosette, J.J.M.C.H. de la, Pes, M.P. Laguna †
Publikováno v:
In The Journal of Urology 2011 186(1):42-46
Autor:
Roland Van Velthoven, Sandrine Marreaud, Peter F.A. Mulders, Christian U. Blank, Sylvie Rottey, Sandra Collette, Johannes V. Van Thienen, Laurence Collette, Thomas Powles, Axel Bex, Lori Wood, Harm H.H.E. Van Melick, Jean Baptiste Lattouf, Igle J. de Jong, John B. A. G. Haanen, John Wagstaff, Bertrand Tombal, Michael A.S. Jewett, M.P. Laguna, Maureen J.B. Aarts
Publikováno v:
JAMA oncology, 5 (2
Translational Cancer Research
JAMA oncology, 5(2), 164-170. AMER MEDICAL ASSOC
JAMA oncology, Vol. 5, no. 2, p. 164-170 (2019)
Jama Oncology, 5, 164-170
Jama Oncology, 5, 2, pp. 164-170
JAMA Oncology, 5(2), 164-170. American Medical Association
Translational Cancer Research
JAMA oncology, 5(2), 164-170. AMER MEDICAL ASSOC
JAMA oncology, Vol. 5, no. 2, p. 164-170 (2019)
Jama Oncology, 5, 164-170
Jama Oncology, 5, 2, pp. 164-170
JAMA Oncology, 5(2), 164-170. American Medical Association
Importance: In clinical practice, patients with primary metastatic renal cell carcinoma (mRCC) have been offered cytoreductive nephrectomy (CN) followed by targeted therapy, but the optimal sequence of surgery and systemic therapy is unknown. Objecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f60e0899118a89e59904c695dfaed4c
https://cris.maastrichtuniversity.nl/en/publications/30d5247a-a32b-4965-a17b-ec5771831809
https://cris.maastrichtuniversity.nl/en/publications/30d5247a-a32b-4965-a17b-ec5771831809
Publikováno v:
Current opinion in urology, 29(1), 70-77. Lippincott Williams and Wilkins
PURPOSE OF REVIEW: Currently, small renal masses account for the largest proportion of renal tumour and small renal cell carcinomas (RCC). Although partial nephrectomy, whenever possible, is recognized as the gold standard for treatment, thermal abla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25c7a7af1bfa2d480f4c29b99e167962
https://doi.org/10.1097/mou.0000000000000559
https://doi.org/10.1097/mou.0000000000000559
Autor:
H. Gremmels, R. Sylvester, Jan Oldenburg, Nicola Nicolai, Christian D. Fankhauser, Carsten Bokemeyer, K. Fizzazi, David Nicol, M.P. Laguna, Joost L. Boormans, Ferran Algaba, J. Mayor De Castro
Publikováno v:
European Urology Open Science, Vol 19, Iss, Pp e1806-e1807 (2020)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac71aff2506761572e2e55f90e901a07
http://www.sciencedirect.com/science/article/pii/S266616832033812X
http://www.sciencedirect.com/science/article/pii/S266616832033812X
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Bernard H. Bochner, Siamak Daneshmand, Georgios Gakis, Surena F. Matin, M.P. Laguna, Mehrdad Alemozaffar, William C. Huang, Shahrokh F. Shariat, Tina Schubert, Arlene O. Siefker-Radtke, Tsunenori Kondo, Steven A. Boorjian, Arnulf Stenzl, Badrinath R. Konety, Joaquim Bellmunt
Publikováno v:
World journal of urology, 35(3), 327-335. Springer Verlag
To provide a comprehensive overview and update of the joint consultation of the International Consultation on Urological Diseases (ICUD) and Societe Internationale d’Urologie for the treatment of localized high-risk upper tract urothelial carcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb177803d3894b6e330928fd7af20c30
https://doi.org/10.1007/s00345-016-1819-1
https://doi.org/10.1007/s00345-016-1819-1